The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
about
Brimonidine in the treatment of glaucoma and ocular hypertensionThe management of glaucoma and intraocular hypertension: current approaches and recent advancesAn emerging treatment option for glaucoma: Rho kinase inhibitorsAqueous shunts with mitomycin C versus aqueous shunts alone for glaucomaMitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgeryAb interno trabecular bypass surgery with Trabectome for open angle glaucomaCombination medical treatment for primary open angle glaucoma and ocular hypertension: a network meta-analysis5-Fluorouracil for glaucoma surgeryMedical versus surgical interventions for open angle glaucomaIntraoperative 5-Fluorouracil for glaucoma surgeryIntraoperative 5-Fluorouracil for glaucoma surgeryOne site versus two site phacotrabeculectomy for primary open angle glaucomaMedical interventions for primary open angle glaucoma and ocular hypertensionScreening for prevention of optic nerve damage due to chronic open angle glaucomaMitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgeryIntraoperative Mitomycin C for glaucoma surgeryMedical versus surgical interventions for open angle glaucomaHow to assess a patient for glaucomaIntegrins in the optic nerve head: potential roles in glaucomatous optic neuropathy (an American Ophthalmological Society thesis)Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosageAb interno trabecular bypass surgery with Trabectome for open angle glaucomaThe Application of a Contact Lens Sensor in Detecting 24-Hour Intraocular Pressure-Related PatternsCanaloplasty: Current Value in the Management of GlaucomaIntracranial Pressure and Its Relationship to Glaucoma: Current Understanding and Future DirectionsVideographic Assessment of Glaucoma Drop InstillationClinical effectiveness of brinzolamide 1%-brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertensionCytidine 5'-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future PerspectivesThe Association between Primary Open-Angle Glaucoma and Blood Pressure: Two Aspects of Hypertension and HypotensionMarijuana for Glaucoma: A Recipe for Disaster or Treatment?The significance of intraocular pressure elevation during sleep-related posturesCombination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focusNovel therapies for open-angle glaucomaTranslating ocular biomechanics into clinical practice: current state and future prospects.Premium intraocular lenses use in patients with cataract and concurrent glaucoma: a reviewRegulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucomaStrategies for improving early detection of glaucoma: the combined structure-function indexIs 24-hour intraocular pressure monitoring necessary in glaucoma?The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional SurveyAssociation between progressive retinal nerve fiber layer loss and longitudinal change in quality of life in glaucomaGaps in Glaucoma care: A systematic review of monoscopic disc photos to screen for glaucoma
P2860
Q22305848-755A4803-B326-4211-B937-E80E0C131B0EQ22305849-17444440-E17C-47E1-8F8F-8A503E55D98FQ22305851-D2F056DE-F4BD-42A9-9ABE-C6EFDB2FC390Q24187514-C6BF62F8-FF9E-48E8-A258-0223C459D445Q24187923-E2A92FC0-9BFE-488B-895B-B395BB0B1651Q24188263-DAB497A7-B161-4A51-8186-60FA76F8F129Q24192958-A6EAF9E3-B843-44FA-8E2B-2FD2BBC78693Q24200343-2730DB72-966E-4DFB-B4C5-D6091E205348Q24200540-77985583-9D43-4718-A969-503AD1DFA0D3Q24234716-77B02521-9497-4C42-B7AC-4452553C9548Q24240539-96CB6DF7-ED0B-4F4C-A840-D135F7591C7BQ24241437-33889BED-40A9-4C9A-8672-EFC5956B7841Q24243220-6857A779-FCE6-4418-B5D9-43689FF8FC7CQ24243996-E58DC1C7-3ECD-4244-9F66-2BB539DA444AQ24244471-51A1EDF3-E3F9-4193-973B-517C879DFF06Q24245549-5CD0452F-1E64-4D13-AF12-E6BDE9261C3EQ24247216-CB762DE5-F52A-4F87-A13A-8B963F4F778FQ24669639-6834CCA9-CBD1-412F-B50E-7C556396B5DBQ24683822-50586945-A1D5-471D-9453-4496A5A306E7Q24811545-EBBD1914-7A6B-4B0C-AF78-09B1049702AAQ26470443-B0C72D12-54D1-42B2-AF62-AC8F65FA1931Q26741482-494D6B6B-D7A1-4819-AC54-ACBB41C9B1D6Q26745167-ABEB54F3-4FD0-4C24-B59B-E33103E70670Q26746426-810E4798-A8F7-4B03-8AD6-DF002B7F8820Q26753171-0884C929-8D2B-4812-B7B3-81F0E57DB3D5Q26773219-9C501D15-D042-4D8C-8F83-ED06522D73F0Q26775083-29353084-1619-4D63-98DD-E8C98833586EQ26777808-E6DFA0A1-E649-4760-B353-4696F775345BQ26785465-A067AC8F-8AA4-429A-846F-AE695C6D13EBQ26825794-DEC699B7-79AE-4F22-B714-97B5C581FDAEQ26830201-7C5A857F-F4EC-4597-9580-EB7279FD951DQ26851132-EAECF230-82F5-45DC-981C-B79E74593CEAQ26852655-43C87082-BBF0-43FC-9B4D-2912D42F4B81Q26853503-126D05CD-820A-411F-B64A-1A12F750A3B2Q26861763-6CC56D71-6916-421B-BB30-52EB34390722Q26997010-D9A41B43-BEB1-40CA-BD58-00D08B587717Q27014089-499D3E8B-2FBA-415C-BBE7-2086A6767CAFQ27304716-C3634AF2-9461-49E4-9896-57E1BD9562FAQ27344981-7B0A76BA-6167-48B7-8A8C-8CA1498CA3A4Q27345105-CA2ABD6F-E299-4319-AAA7-8E2F4243F68D
P2860
The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
The Ocular Hypertension Treatm ...... f primary open-angle glaucoma.
@en
The Ocular Hypertension Treatm ...... f primary open-angle glaucoma.
@nl
type
label
The Ocular Hypertension Treatm ...... f primary open-angle glaucoma.
@en
The Ocular Hypertension Treatm ...... f primary open-angle glaucoma.
@nl
prefLabel
The Ocular Hypertension Treatm ...... f primary open-angle glaucoma.
@en
The Ocular Hypertension Treatm ...... f primary open-angle glaucoma.
@nl
P2093
P1433
P1476
The Ocular Hypertension Treatm ...... of primary open-angle glaucoma
@en
P2093
Dale K Heuer
Eve J Higginbotham
J Philip Miller
John L Keltner
M Roy Wilson
Mae O Gordon
Michael A Kass
Richard K Parrish
P304
701-13; discussion 829-30
P356
10.1001/ARCHOPHT.120.6.701
P407
P577
2002-06-01T00:00:00Z